Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Boston Innovation Capital (BIC) is a specialized advisory firm and FINRA-registered broker-dealer that supports early-stage life science companies in their fundraising and strategic partnership efforts. As a subsidiary of Life Science Nation (LSN), the firm leverages a deep global network of investors and pharmaceutical partners to facilitate connections for startups in the biotech, medical device, diagnostics, and healthcare IT sectors. BIC provides both sell-side services, such as executing global fundraising campaigns, and buy-side services, including sourcing and assessing technology assets for acquisition or licensing. The company operates at the intersection of the North American and European life science ecosystems, utilizing LSN's extensive database and RESI conference series to identify high-potential innovations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Boston Innovation.